Artiva Biotherapeutics (ARTV)
Develops cryopreserved allogeneic NK-cell candidates for autoimmune diseases and cancer.
$8.09
After hours−0.01 (−0.06%)
At close$8.10(+3.38%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
estimated · in 50 days
EPS estimate
−$0.54
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.66−$0.83−$0.87−$0.88−$0.84−$0.95−$0.63Pending
Estimate−$0.71−$0.68−$0.84−$0.92−$0.87−$0.88−$0.63−$0.54
Surprise+7.0%−22.1%−3.6%+4.3%+3.4%−8.0%−0.8%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2030 | $0.09 | — | — |
| Sep 2030 | −$0.11 | — | — |
| Jun 2030 | −$0.31 | — | — |
| Mar 2030 | −$0.53 | — | — |
| Dec 2029 | −$0.65 | — | — |
| Sep 2029 | −$0.76 | — | — |
| Jun 2029 | −$0.79 | — | — |
| Mar 2029 | −$0.76 | — | — |
| Dec 2028 | −$0.79 | — | — |
| Sep 2028 | −$0.84 | — | — |
| Jun 2028 | −$0.80 | — | — |
| Mar 2028 | −$0.76 | — | — |
| Dec 2027 | −$0.66 | — | — |
| Sep 2027 | −$0.65 | — | — |
| Jun 2027 | −$0.62 | — | — |
| Mar 2027 | −$0.64 | — | — |
| Dec 2026 | −$0.59 | — | — |
| Nov 2026 | −$0.54 | — | — |
| Aug 2026 | −$0.63 | −$0.63 | −0.8% |
| May 2026 | −$0.88 | −$0.95 | −8.0% |
| Mar 2026 | −$0.87 | −$0.84 | +3.4% |
| Nov 2025 | −$0.92 | −$0.88 | +4.3% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Jun 2024 | |||
| Dec 2023 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| Mar 2023 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2030 | $0.09 | — | — | $68.0M | — | — | — |
| Sep 2030 | −$0.11 | — | — | $53.5M | — | — | — |
| Jun 2030 | −$0.31 | — | — | $38.2M | — | — | — |
| Mar 2030 | −$0.53 | — | — | $22.8M | — | — | — |
| Dec 2029 | −$0.65 | — | — | $12.0M | — | — | — |
| Sep 2029 | −$0.76 | — | — | $3.7M | — | — | — |
| Jun 2029 | −$0.79 | — | — | $0 | — | — | — |
| Mar 2029 | −$0.76 | — | — | $0 | — | — | — |
| Dec 2028 | −$0.79 | — | — | $0 | — | — | — |
| Sep 2028 | −$0.84 | — | — | $0 | — | — | — |
| Jun 2028 | −$0.80 | — | — | $0 | — | — | — |
| Mar 2028 | −$0.76 | — | — | $0 | — | — | — |
| Dec 2027 | −$0.66 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.65 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.62 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.64 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.59 | — | — | $0 | — | — | — |
| Nov 11, 2026 | −$0.54 | — | — | $0 | — | — | — |
| Aug 6, 2026 | −$0.63 | −$0.63 | −0.8% | — | — | — | −2.7% |
| May 8, 2026 | −$0.88 | −$0.95 | −8.0% | — | — | — | −13.0% |
| Mar 10, 2026 | −$0.87 | −$0.84 | +3.4% | — | — | — | +6.5% |
| Nov 12, 2025 | −$0.92 | −$0.88 | +4.3% | — | — | — | +10.9% |
| Aug 6, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 25, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 29, 2024 | |||||||
| Jun 28, 2024 | |||||||
| Dec 31, 2023 | |||||||
| Sep 30, 2023 | |||||||
| Jun 30, 2023 | |||||||
| Mar 31, 2023 |